Citigroup
ROIV icon

Citigroup’s Roivant Sciences ROIV Stock Holding History

Citigroup’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.08M Buy
29,400
+2,400
+9% +$87K ﹤0.01% 3261
2026
Q2 		$956K Hold
27,000
– – ﹤0.01% 3474
2026
Q1 		$748K Buy
+27,000
New +$694K ﹤0.01% 3304

Other funds holding ROIV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Penn Davis McFarland
Penn Davis McFarland Dallas, Texas $1.17B AUM 26.22% 1-Year Est. Return
Parkside Financial Bank & Trust
Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Citigroup's ROIV Position: Q3 2026 in Review

Citigroup increased its Roivant Sciences (ROIV) stake by 25% in Q3 2026, buying an estimated $20M and bringing the position to 2,777,582 shares worth $102M. The position accounts for 0.03% of the portfolio, ranked #497.

Citigroup first reported a position in ROIV in Q4 2021 and has held it in 20 quarters since. 181 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Citigroup held 2,777,582 shares of Roivant Sciences worth $102M as of Q3 2026.
  • Citigroup bought 552,392 Roivant Sciences shares in Q3 2026, an estimated $20M.
  • Roivant Sciences made up 0.03% of Citigroup's portfolio in Q3 2026, its #497 holding.
  • Citigroup first reported a position in Roivant Sciences in Q4 2021 and has held it in 20 quarters since.
  • 181 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.